Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Pregabalin for neuropathic pain in adults.

< BACK TO ARCHIVE


Papers: 19 Jan 2019 - 25 Jan 2019


Pharmacology/Drug Development


2019 Jan 23


Cochrane Database Syst Rev


http://www.ncbi.nlm.nih.gov/pubmed/30673120?dopt=Abstract


1

Pregabalin for neuropathic pain in adults.

Authors

Pregabalin for neuropathic pain in adults.
Derry S, Bell R F, Straube S, Wiffen PJ, Aldington D, Moore AR
Cochrane Database Syst Rev. 2019 Jan 23; 1:CD007076.
PMID: 30673120.

Abstract

This review updates part of an earlier Cochrane Review titled "Pregabalin for acute and chronic pain in adults", and considers only neuropathic pain (pain from damage to nervous tissue). Antiepileptic drugs have long been used in pain management. Pregabalin is an antiepileptic drug used in management of chronic pain conditions.
Read This Paper